62 related articles for article (PubMed ID: 11014584)
1. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Pim-1 during progression of prostatic adenocarcinoma.
Cibull TL; Jones TD; Li L; Eble JN; Ann Baldridge L; Malott SR; Luo Y; Cheng L
J Clin Pathol; 2006 Mar; 59(3):285-8. PubMed ID: 16505280
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of prostate cancer at autopsy in Nigeria-A preliminary report.
Bosland MC; Nettey OS; Phillips AA; Anunobi CC; Akinloye O; Ekanem IA; Bassey IE; Mehta V; Macias V; van der Kwast TH; Murphy AB
Prostate; 2021 Jun; 81(9):553-559. PubMed ID: 33905137
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion.
Moussalli MJ; Wu Y; Zuo X; Yang XL; Wistuba II; Raso MG; Morris JS; Bowser JL; Minna JD; Lotan R; Shureiqi I
Cancer Prev Res (Phila); 2011 Dec; 4(12):1961-72. PubMed ID: 21881028
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis.
Mohsenzadegan M; Madjd Z; Asgari M; Abolhasani M; Shekarabi M; Taeb J; Shariftabrizi A
Cancer Immunol Immunother; 2013 Oct; 62(10):1609-18. PubMed ID: 23955683
[TBL] [Abstract][Full Text] [Related]
6. Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization.
Giner Moreno E; Quereda-Flores F; Hernández Chinchilla JA; Amigo Moreno R; Perez Ruiz MD; Carcelén López A; Rocher Benlloch J; Molió Sanchís P; Casares Calzada A; Marqués-Torrejón MÁ; Martínez-Cadenas C; Ruiz Cerdá JL; Loras Monfort A; Ramos Soler D
J Vis Exp; 2023 Nov; (201):. PubMed ID: 38047572
[TBL] [Abstract][Full Text] [Related]
7. Incidental Prostatic Adenocarcinoma in Open Prostatectomy Specimens: An Institutional Experience.
Omenai SA; Fashola OA; Takure AO; Ogunbiyi JO
Niger Med J; 2021; 62(6):298-304. PubMed ID: 38736511
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Relationship between E-Cadherin and β-Catenin Cell Adhesion Proteins and Periacinar Retraction Clefting in Prostatic Adenocarcinoma.
Limani R; Lež C; Krušlin B
Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472982
[TBL] [Abstract][Full Text] [Related]
9. Increased aPKC Expression Correlates with Prostatic Adenocarcinoma Gleason Score and Tumor Stage in the Japanese Population.
Perry AS; Furusato B; Nagle RB; Ghosh S
Prostate Cancer; 2014; 2014():481697. PubMed ID: 24868468
[TBL] [Abstract][Full Text] [Related]
10. Updates of Prostate Cancer from the 2022 World Health Organization Classification of the Urinary and Male Genital Tumors.
Guo CC; Czerniak B
J Clin Transl Pathol; 2023; 3(1):26-34. PubMed ID: 38605939
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Cytokeratin-7 and Cytokeratin-19 Expression Relationship with Gleason Score in Prostatic Adenocarcinoma.
Soltanipur M; Jalali Nadoushan M; Yarmohammadi H
Iran J Pathol; 2023; 18(3):363-369. PubMed ID: 37942200
[TBL] [Abstract][Full Text] [Related]
12. Arachidonate 15-lipoxygenase type B: Regulation, function, and its role in pathophysiology.
Benatzy Y; Palmer MA; Brüne B
Front Pharmacol; 2022; 13():1042420. PubMed ID: 36438817
[TBL] [Abstract][Full Text] [Related]
13. Investigating the effects of two novel 4-MMPB analogs as potent lipoxygenase inhibitors for prostate cancer treatment.
Iranpour S; Al-Mosawi AKM; Bahrami AR; Sadeghian H; Matin MM
J Biol Res (Thessalon); 2021 May; 28(1):10. PubMed ID: 33947474
[TBL] [Abstract][Full Text] [Related]
14. Regulation and Functions of 15-Lipoxygenases in Human Macrophages.
Snodgrass RG; Brüne B
Front Pharmacol; 2019; 10():719. PubMed ID: 31333453
[TBL] [Abstract][Full Text] [Related]
15. The Relationship between Eicosanoid Levels and Serum Levels of Metabolic and Hormonal Parameters Depending on the Presence of Metabolic Syndrome in Patients with Benign Prostatic Hyperplasia.
Grzesiak K; Rył A; Stachowska E; Słojewski M; Rotter I; Ratajczak W; Sipak O; Piasecka M; Dołęgowska B; Laszczyńska M
Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30897712
[No Abstract] [Full Text] [Related]
16. Eicosanoids and cancer.
Gomes RN; Felipe da Costa S; Colquhoun A
Clinics (Sao Paulo); 2018 Aug; 73(suppl 1):e530s. PubMed ID: 30133566
[TBL] [Abstract][Full Text] [Related]
17. Effect of β-sitosterol against methyl nitrosourea-induced mammary gland carcinoma in albino rats.
Manral C; Roy S; Singh M; Gautam S; Yadav RK; Rawat JK; Devi U; Ansari MN; Saeedan AS; Kaithwas G
BMC Complement Altern Med; 2016 Jul; 16():260. PubMed ID: 27473871
[TBL] [Abstract][Full Text] [Related]
18. A high throughput screen identifies potent and selective inhibitors to human epithelial 15-lipoxygenase-2.
Jameson JB; Kantz A; Schultz L; Kalyanaraman C; Jacobson MP; Maloney DJ; Jadhav A; Simeonov A; Holman TR
PLoS One; 2014; 9(8):e104094. PubMed ID: 25111178
[TBL] [Abstract][Full Text] [Related]
19. Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer.
Suraneni MV; Moore JR; Zhang D; Badeaux M; Macaluso MD; DiGiovanni J; Kusewitt D; Tang DG
Cell Cycle; 2014; 13(11):1798-810. PubMed ID: 24732589
[TBL] [Abstract][Full Text] [Related]
20. Roles of Eicosanoids in Prostate Cancer.
Nithipatikom K; Campbell WB
Future Lipidol; 2008 Aug; 3(4):453-467. PubMed ID: 24563660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
